UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Deborah Wong, MD, PhD

Print
Email

Deborah Jean Lee Wong, MD, PhD

UCLA Physician Deborah Jean Lee  Wong, MD, PhD specializes in Hematology & Oncology.
Specialty
Hematology & Oncology
Gender
Female
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License Number
A101243
Contact
(310) 794-4955 Westwood
(310) 829-5471 Santa Monica
Fax Number
(310) 443-0477 Westwood
(310) 829-6192 Santa Monica
PRACTICE LOCATION

Westwood Office
100 UCLA Medical Plaza, Suite 550
Los Angeles, CA 90095

Santa Monica Office
2020 Santa Monica Blvd, Suite 600
Santa Monica, CA 90404

MEDICAL BOARD CERTIFICATION
Medical Oncology, American Board of Internal Medicine, 2013
Hematology, American Board of Internal Medicine, 2013
Internal Medicine, American Board of Internal Medicine, 2009
EDUCATION
Fellowship
Hematology & Medical Oncology, UCLA School of Medicine, 2010 - 2013
Residency
Internal Medicine, UCLA School of Medicine, 2007 - 2009
Internship
Internal Medicine, UCLA School of Medicine, 2006 - 2007
Degree
MD, UC Irvine College of Medicine, 2006
CLINICAL INTEREST
Advanced Malignancies, Antiphospholipid, Biliary, Breast, Cancers of the Digestive Tract, Chronic Myelogenous Leukemia, Esophageal Cancer, Gastrointestinal Malignancies, General Hematology, General Oncology, Genitourinary, Geriatric Lung Cancer, Head and Neck Cancers, Hematologic Malignancies, Hepatobiliary Cancers, Laryngeal Cancer, Lung Cancer & Chest Malignancies, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Renal, Sarcoma, Sickle Cell Anemia, Unknown Primary, Waldenstrom's Disease
AFFILIATION
MORE INFORMATION
Research Interest
Clinical and Research Interests: Head and Neck, Lung
Additional Information
  • PhD, Biological Sciences, University of California, Irvine, 2005 Chief Resident, Medicine, University of California, Los Angeles, 2009-2010
  • Chief Fellow, Hematology-Oncology, University of California, Los Angeles, 2012-2013
Publications
  1. Fratiello, A., Kubo-Anderson, V., Lee, D.J., Perrigan, R.D., and Wong, K. A Direct Carbon-13 and Nitrogen-15 NMR Study of Samarium(III)-Isothiocyanate Complexation in Aqueous Solvent Mixtures. Journal of Solution Chemistry. 1998: 27, 581-600.
  2. Fratiello, A., Kubo-Anderson, V., Lee, D.J., Mao, T., Ng, K., Nickolaisen, S., Perrigan, San Lucas, V., Tikkanen, W., Wong, A., and Wong, K. Multinuclear Magnetic Resonance Study of Zinc(II) and Cadmium(II) Complexing with Isothiocyanate. Journal of Solution Chemistry. 1998: 27, 331-359.
  3. Fratiello, A., Kubo-Anderson, V., Lee, D.J., Perrigan, R.D. and Wong, K. A Direct Carbon-13 and Nitrogen-15 NMR Study of Cerium(III)-Isothiocyanate Complexation in Aqueous Solvent Mixtures. Journal of Solution Chemistry. 1999. 28, 193- 210.
  4. Reinke, R., Lee, D.J., Robinson W.E. Jr. Inhibition of human immunodeficiency virus type 1 isolates by the integrase inhibitor L-731,988, a diketo Acid. Antimicrob Agents Chemother. 2002 Oct;46(10):3301-3.
  5. Victoria, J.G., Lee, D.J., McDougall, B.R., Robinson, W.E., Jr. Replication Kinetics for Divergent Type 1 Human Immunodeficiency Viruses Using Quantitative SYBR Green I Real-Time Polymerase Chain Reaction. AIDS Research and Human Retroviruses. 2003; 19:865-874.
  6. King, P.J., Lee, D.J., Reinke, R., Victoria J.G., Beale K., and Robinson, W.E., Jr. Human Immunodeficiency Virus Type-1 Integrase Containing a Glycine to Serine Mutation at Position 140 is Attenuated for Catalysis and Resistant to Integrase Inhibitors. Virology. 2003; 306:147-161.
  7. Reinke, R., Lee, D.J., McDougall, B.R., King, P.J., Victoria, J., Mao, Y., Lei, X., Reinecke, M.G., Robinson, W.E., Jr. L-Chicoric Acid Inhibits Human Immunodeficiency Virus Type 1 (HIV-1) Integration In Vivo and is a Non-Competitive but Reversible Inhibitor of HIV-1 Integrase In Vitro. Virology. 2004. 326: 203-219.
  8. Lee, D.J. and Robinson, W.E., Jr. Human Immunodeficiency Virus Type 1 (HIV-1) Integrase: Resistance to Integrase Inhibitors Impairs Replication, Integration, and Confers Cross-Resistance to L-Chicoric Acid and L-731,988. Journal of Virology. 2004; 78: 5835-5847.
  9. Charvat, T., Lee, D.J., Chamberlin, A.R., and Robinson, W.E., Jr. Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase. Bioorg Med Chem. 2006; 14: 4552-4567.
  10. Lee, D.J., and Robinson, W.E., Jr. Mutagenesis Confirms a Putative Human Immunodefiency Virus Integrase Inhibitor-Binding Pocket First Proposed by Molecular Modeling. Antimicrobial Agents and Chemotherapy. 2006; 50: 134-142.
  11. von Euw E, Atefi M, Attar N, Chu C, Zachariah S, Burgess BL, Mok S, Ng C, Wong DJ, Chmielowski B, Lichter DI, Koya RC, McCannel TA, Izmailova E, Ribas A. Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines. Mol Cancer. 2012 Apr 19;11(1):22.
  12. Wong, D.J.L., Tap, W. D., and Marder, V.J. Liver Transplantation for Hematological Disorders. in Busuttil, R.W. and Klintmalm, G.B. Transplantation of the Liver, 3rd edition. Elsevier, 2013.
  13. Lassen,A., Atefi, M., Wong, D.J., Robert, L., Cerniglia, M., Comin-Anduix, B., Ribas, A. Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma. Molecular Cancer. 2014 Apr 16;13(1):83. PMID: 24735930.
  14. Chodon, T., Comin-Anduix, B., Chmielowski, B., Koya, R.C., Wu, Z., Auerbach, M., Ng, C., Avramis, E.A., Seja, E., Villanueva, A., McCannel, T., Ishiyama, A., Czernin, J., Radu, C.G., Wang, X., Giertson, D.W., Cochran, A.J., Cornetta, K., Wong, DJ, Kaplan-Lefko, P., J., Hamid, O., Samlowski, W., Cohen, P.A., Daniels, G.A., Mukherji, B., Yang, L., Zack, J., Kohn, D., Heath, J., Glaspy, J., Witte, O., Baltimore, D., Economou, J., Ribas, A. Adoptive cell transfer of MART-1 TCR transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clinical Cancer Research. Clin Cancer Res. 2014 May 1;20(9):2457-2465. Epub 2014 Mar 14. PMID: 24634374.
  15. Wong, D.L., Rao, A., Avramis, E., Matsunaga, D.R., Komatsubara, K.M., Chodon, T. , Koya, R.C., Ribas, A. and Comin-Anduix, B. Detrimental Effects of a Histone Deacetylase Inhibitor on Human Lymphocytes. Cancer Immunol Res, 2014, May 2014 2; 459. PMID: 24795358.
  16. Atefi, M., Avramis, E., Lassen, A., Wong, D.J., Robert, L., Foulad, D., Cerniglia, M., Titz, B., Chodon, T., Graeber, T.G., Comin-Anduix, B., Ribas, A., Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma. Clinical Cancer Research. 2014, May 8. PMID: 24812408.
Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Deborah Wong, click here to update your profile.